Baby boomers and ‘Ozempic face’ drive injectables craze
Baby boomers and users of weight loss drugs suffering from “facial sagging” are flocking to injectable aesthetic treatments ...
Healio7d
Sculptra, hyaluronic filler regimen corrects facial sagging from GLP-1-induced weight loss
New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients ...
‘Ozempic face’ drives surge in sale of cosmetic fillers
Users of weight-loss drugs are seeking help from dermatologists to rectify ‘facial sagging’ after shedding the pounds ...
Forbes5mon
Why L’Oréal Dermatological Beauty Is Gaining Traction And Luxury Isn’t
L’Oréal just announced it acquired a 10% stake in Galderma, characterized as a “pure play dermatology leader” in injectibles with Botox-competitor Dysport, and Restylane filler brands.
pharmaphorum1mon
Galderma adds new indication for blockbuster hope Nemluvio
Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to its label. Nemluvio (nemolizumab) – which was approved by the FDA in ...
pharmaphorum5mon
Galderma gets FDA nod for prurigo nodularis therapy
Dermatology specialist Galderma has FDA approval for prurigo nodularis treatment Nemluvio, one of two new drugs that it thinks will deliver blockbuster sales. The US regulator cleared the IL-31 ...
Business Wire1mon
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and ...